Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950123-10-093862
Filing Date
2010-10-18
Accepted
2010-10-18 16:05:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 o65842e424b3.htm 424B3 395065
2 GRAPHIC o65842o6584202.gif GRAPHIC 4633
  Complete submission text file 0000950123-10-093862.txt   403074
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-160251 | Film No.: 101128151
SIC: 2835 In Vitro & In Vivo Diagnostic Substances